Alzheimer’s – An updated review on disease and its treatment

Journal Title: World Journal of Pharmaceutical Sciences - Year 2016, Vol 4, Issue 2

Abstract

Alzheimer’s disease (AD) is the most common cause of cognitive impairment in older patients and is expected to increase greatly in prevalence in the next future. An excess of senile plaques (h-amyloid protein) and neurofibrillary tangles (tau protein), ventricular enlargement, and cortical atrophy characterizes it. A cascade of pathophysiological events is triggered in AD that ultimately involves common cellular signaling pathways and leads to cellular and neural networks dysfunction, failure of neurotransmission, cell death and a common clinical outcome. A major focus of drug treatment for Alzheimer's disease is to improve cognitive abilities such as memory and thinking and slow the progression of these symptoms. Current treatments cannot cure or halt the disease, but can offer some people modest improvement in some symptoms. Countless new treatments are in development, so more options will be available in the near future. This article consists of a critical review of Alzheimer’s disease (AD), its epidemiology, patterns of care, prognostic factors, and symptomatic strategies available for treating AD and future strategies for improving our therapeutic approach to AD.

Authors and Affiliations

Sayantan Mukhopadhyay Mukhopadhyay

Keywords

Related Articles

Importance of herbaria in herbal drug discovery

The conservation of traditional medicinal knowledge opens the door towards modern aspects of herbal drug discovery. It was started from knowledge exchange through ethnic groups by oral tradition and then in the documente...

Atorvastatin can meritoriously improve the quality of life of chronic obstructed pulmonary disorder patients

Objective: To demonstrate the impact of Atorvastatin on heath associated quality of life in chronic obstructive pulmonary disease patients. Methodology: This interventional study carried out in the department of Pharmaco...

Levofloxacin Induced Angioedema: A Case Report

Levofloxacin is a broad spectrum antibiotic of the class third generation fluroquinolone. A 48yr old female patient is on levofloxacin antibiotic for fever develop itching and swelling of the eye and leg on the third day...

Management of Recurrent urinary tract infection in diabetic patient with Ayurveda and counselling- Case study

A female patient of 56 years came to the Diabetic screening and counselling OPD of Ayurveda and Unani Tibbia college & hospital in February 2015 with chief complaints of increased frequency of micturition and burning sen...

Recent trends in microencapsulation: A review

Microcapsules are tiny capsules containing materials (such as adhesive or a medicine) that are released when the capsule is broken, melted or dissolved. The process of forming microcapsules is called microencapsulation....

Download PDF file
  • EP ID EP195448
  • DOI -
  • Views 92
  • Downloads 0

How To Cite

Sayantan Mukhopadhyay Mukhopadhyay (2016). Alzheimer’s – An updated review on disease and its treatment. World Journal of Pharmaceutical Sciences, 4(2), 204-211. https://europub.co.uk/articles/-A-195448